Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
product_txtF_mv:"National Center for Biotechnology Information"
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
20
of
204
Search:
''
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Tapentadol hydrochloride (Nucynta extended-release -- Paladin Labs Inc.) : indication : management of pain severe enough to req...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication : for the symptomatic treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
6
CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Obeticholic acid (Ocaliva--Intercept Pharmaceuticals Canada) : indication : primary biliary cholangitis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...
Published 2019
CADTH
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...
Published 2018
CADTH
Read Now
13
Optimal use of minimally invasive glaucoma surgery: A health technology assessment : project protocol
Published 2018
CADTH
Read Now
14
CADTH Canadian drug expert committee recommendation: Benralizumab (Fasenra -- Astrazeneca Canada Inc.) : indication : severe eosinophilic asthma
Published 2018
CADTH
Read Now
15
Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)
Published 2019
CADTH
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical Care Renal Pharma Ltd.) : indication : for the control of serum p...
Published 2019
CADTH
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Collection: National Center for Biotechnology Information
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
192
330 - Economics
111
140 - Specific philosophical schools
24
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
2
800 - Literature & rhetoric
2
Language
English
204
Collection
National Center for Biotechnology Information
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
152
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&type=AllFields
Send by Email
×
Loading...